Neuronetics appoints Nir Naor as EVP, CFO and Treasurer; W. Andrew Macan to depart
Less than 1 min read
Neuronetics appointed Nir Naor as Executive Vice President, Chief Financial Officer and Treasurer, effective on or about July 23, 2026, while W. Andrew Macan will depart as Executive Vice President, Chief Legal Officer and Corporate Secretary with a Separation Date of August 15, 2026.
| Individual | W. Andrew Macan | Nir Naor |
| Role | Executive Vice President, Chief Legal Officer, Corporate Secretary | Executive Vice President, Chief Financial Officer, Treasurer |
| Type of Change | Separation / Departure | Appointment |
| Effective Date | August 15, 2026 | On or about July 23, 2026 |
| Reason | Not the result of any dispute or disagreement with the Company, management, or Board | Not disclosed |
| Replacement Info | Not disclosed | N/A |
| Background Details | Served in role since January 21, 2020; Separation Agreement provides retention bonus, vested RSUs and separation payment | Age 51; 20+ years finance and life sciences experience; prior CFO roles at Axogen, HMNC Brain Health, Arbor Pharmaceuticals; senior finance roles at Molnlycke, UCB, AstraZeneca; MBA (IMD), LL.M. (Hamburg), LL.B. and accounting degrees (Tel-Aviv University); CFA® charterholder |
| Board/Committee Role Changes | Not disclosed | Not disclosed |
Original SEC Filing: Neuronetics, Inc. [ STIM ] - 8-K - Jul. 20, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.